SCHEMBL5051008

SCHEMBL5051008

CC(Sc1ccccn1)c1ccccc1C(=O)NCCCCCC(=O)ON1C(=O)CC(S(=O)(=O)O)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HCRTR1 O43613 1/20 0.32
HDAC3 O15379 4/20 0.32
HDAC1 Q13547 4/20 0.32
HDAC4 P56524 2/20 0.32
HDAC7 Q8WUI4 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC10 Q969S8 2/20 0.32
HDAC11 Q96DB2 2/20 0.32
HDAC8 Q9BY41 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
HDAC9 Q9UKV0 2/20 0.32
HDAC5 Q9UQL6 2/20 0.32
PDPK1 O15530 1/20 0.32
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
HTT P42858 1/20 0.31
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30031578 0.93 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2HCRTR1HDAC3HDAC1
SCHEMBL346020 0.93 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2HCRTR1HDAC3HDAC1
SCHEMBL900949 0.88 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2HDAC3HDAC6KMT2A
SCHEMBL321300 0.83 SMN1; SMN2 (0.35) ALDH1A1SMN1; SMN2HDAC3HDAC6KMT2A
SCHEMBL182506 0.81
SCHEMBL8741061 0.80 SMN1; SMN2 (0.32) ALDH1A1SMN1; SMN2HDAC3HDAC1HDAC4
SCHEMBL2283058 0.80 HPGD (0.46) ALDH1A1SMN1; SMN2KMT2AL3MBTL1HPGD
SCHEMBL9136880 0.79 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2HDAC3HDAC1HDAC4
SCHEMBL29361373 0.79 HPGD (0.37) ALDH1A1SMN1; SMN2HDAC3HDAC1HDAC4
SCHEMBL44111 0.79 HPGD (0.37) ALDH1A1SMN1; SMN2HDAC3HDAC1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005086775-A2 LUMEN-EXPOSED MOLECULES AND METHODS FOR TARGETED DELIVERY UTAH VENTURES II, L.P. (US) 2005-09-22 WO claimed
US-20040146516-A1 Lumen-exposed molecules and methods for targeted delivery UTAH VENTURES II L.P. 2004-07-29 US claimed
EP-4683674-A1 COMPOSITIONS AND METHODS FOR DELIVERING ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR EXON SKIPPING Yale University (US) 2026-01-28 EP disclosed
EP-4655007-A1 ANTIBODY OLIGONUCLEOTIDE CONJUGATES Yale University (US) 2025-12-03 EP disclosed
WO-2024197302-A1 COMPOSITIONS AND METHODS FOR DELIVERING ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR EXON SKIPPING YALE UNIVERSITY (US) 2024-09-26 WO disclosed
WO-2024158824-A1 ANTIBODY OLIGONUCLEOTIDE CONJUGATES YALE UNIVERSITY (US) 2024-08-02 WO disclosed
US-20230248852-A1 Nanoparticle Photoacoustic Imaging Agents THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2023-08-10 US disclosed
US-11548953-B2 Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-01-10 US disclosed
US-10905775-B2 Particulate constructs for release of active agents CELATOR PHARMACEUTICALS, INC. (US) 2021-02-02 US disclosed
US-20200054772-A1 Nanoparticle Photoacoustic Imaging Agents THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2020-02-20 US disclosed
US-20180221509-A1 PARTICULATE CONSTRUCTS FOR RELEASE OF ACTIVE AGENTS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2018-08-09 US disclosed
US-20170042823-A1 CO-ENCAPSULATION OF ANTIMICROBIALS AND ADJUVANTS IN NANOCARRIERS UNIV PRINCETON (US) 2017-02-16 US disclosed
US-20160082134-A1 Nanoparticle Photoacoustic Imaging Agents THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-03-24 US disclosed
US-20130336915-A1 PARTICULATE CONSTRUCTS FOR RELEASE OF ACTIVE AGENTS Jazz Pharmaceuticals Therapeutics, Inc. 2013-12-19 US disclosed
US-20130337078-A1 PARTICULATE CONSTRUCTS FOR RELEASE OF ACTIVE AGENTS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-12-19 US disclosed
US-20080299205-A1 Particulate Constructs For Release of Active Agents CELATOR PHARMACEUTICALS, INC. 2008-12-04 US disclosed